XML 45 R33.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT INFORMATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Segment Reporting Information by Segment | Revenue, cost of sales and gross profit for each of our reportable segments were as follows:
| Three Months Ended |  | Nine Months Ended
(in thousands) | September 30, 2025 |  | September 30, 2024 |  | September 30, 2025 |  | September 30, 2024
Revenue: |  |  |  |  |  |  |
Healthcare Solutions | $ | 42,787 |  |  | $ | 55,056 |  |  | $ | 129,123 |  |  | $ | 149,369 |
Industrial Solutions | 48,462 |  |  | 57,884 |  |  | 151,504 |  |  | 179,728 |
Total revenue | 91,249 |  |  | 112,940 |  |  | 280,627 |  |  | 329,097 |
Cost of sales: |  |  |  |  |  |  |
Healthcare Solutions | 26,367 |  |  | 31,734 |  |  | 76,297 |  |  | 86,630 |
Industrial Solutions | 35,451 |  |  | 39,493 |  |  | 106,060 |  |  | 112,734 |
Total cost of sales | 61,818 |  |  | 71,227 |  |  | 182,357 |  |  | 199,364 |
Gross profit: |  |  |  |  |  |  |
Healthcare Solutions | 16,420 |  |  | 23,322 |  |  | 52,826 |  |  | 62,739 |
Industrial Solutions | 13,011 |  |  | 18,391 |  |  | 45,444 |  |  | 66,994 |
Total gross profit | 29,431 |  |  | 41,713 |  |  | 98,270 |  |  | 129,733 |
Selling, general and administrative | 34,716 |  |  | 57,974 |  |  | 118,624 |  |  | 166,772 |
Research and development | 16,025 |  |  | 20,764 |  |  | 53,069 |  |  | 66,260 |
Asset impairment charges | — |  |  | 143,733 |  |  | — |  |  | 143,733 |
Foreign exchange gain (loss), net | 2,623 |  |  | (1,960) |  |  | 2,171 |  |  | (774) |
Interest income | 784 |  |  | 1,550 |  |  | 3,454 |  |  | 5,800 |
Interest expense | (1,924) |  |  | (606) |  |  | (3,202) |  |  | (1,944) |
Gain on disposition | — |  |  | — |  |  | 125,681 |  |  | — |
Other income (loss), net | 475 |  |  | (51) |  |  | 7,335 |  |  | 21,719 |
Net (loss) income before income taxes | $ | (19,352) |  |  | $ | (181,825) |  |  | $ | 62,016 |  |  | $ | (222,231) |
Depreciation and amortization included in the measurement of gross profit by segment were as follows:
| Three Months Ended |  | Nine Months Ended
(in thousands) | September 30, 2025 |  | September 30, 2024 |  | September 30, 2025 |  | September 30, 2024
Depreciation and amortization: |  |  |  |  |  |  |
Healthcare Solutions | $ | 1,385 |  |  | $ | 1,289 |  |  | $ | 4,070 |  |  | $ | 4,009 |
Industrial Solutions | $ | 493 |  |  | $ | 726 |  |  | $ | 1,786 |  |  | $ | 2,257 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration